Trial Profile
A trial to evaluate the effects of continuous treatment with denosumab in patients with rheumatoid arthritis (RA) and osteoporosis (OP)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Jun 2019
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Postmenopausal osteoporosis; Rheumatoid arthritis
- Focus Therapeutic Use
- 18 May 2016 Primary endpoint (Changes from baseline at 12- and 24-month in BMD) has been met according to a results presented at the 2016 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
- 18 May 2016 New trial record
- 17 Apr 2016 Results presented at the 2016 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases